Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on... see more

CSE:QNTM - Post Discussion

Quantum BioPharma Ltd > Biotechs didn’t need revenues to be worth billions
View:
Post by DavidRosenberg on Nov 03, 2021 4:26am

Biotechs didn’t need revenues to be worth billions

Don't always need revenues, they need results from trials 

https://www.toptal.com/finance/valuation/biotech-valuation
Comment by Mil_Man54 on Nov 03, 2021 8:36am
Rosenberg has no idea what he's talking about and is definitely trying to mislead investors by not adding some context to that statement.....specualtion of a company and its potential can drive the SP up dramatically creating a worth of billions...but that ship has long sailed for FSD....they used up all their good will with investors through their corrupt dealings and mismanagement which IMO ...more  
Comment by Renofund on Nov 03, 2021 10:25am
Ben graham reference didnt work, do pivot to this LOL.  You are right, they dont necessarily need revenues.  What does this article talk about that FSD doesnt have?!? Hmmmm.  Do better.
Comment by GrahamB on Nov 03, 2021 11:26am
If you read the article, the key sentence is "track record of the company (its R&D and regulatory teams) in getting drugs approved" Therin lies the reason why FSD is worth sub penny-it has no success in the area The track record is abysmal Shall I post it again? "To calculate the probability of success for a drug candidate, as a general principle, we should be "good ...more  
Quantum BioPharma Ltd
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities